Molecular diagnostics include clinical tests with nucleic acid analytes or targets and represent some of the fastest growing and most dynamic clinical diagnostics markets. Exceeding $6 billion in global market volume, clinical molecular diagnostics are the leading application of nucleic acid tests. Kalorama Information offers specialized research in related markets of molecular point-of-care (POC) diagnostics, next-generation sequencing (NGS), molecular infectious disease diagnostics, and cancer diagnostics. Included in this section is information on the latest in molecular screening that catches infectious diseases such as HIV and Influenza, offering developments in the market soon to be used in molecular diagnostic treatments. Find the most up to date information on devices already on the market or still in development that will quickly determine appropriate treatment methods for patients, and understand the paradigm shift from curative medicine to predictive, personalized, and preemptive patient treatment.
- Display 15 Products per page
Published: June 22, 2017 | Price: $2,800.00 – $5,600.00
The PCR testing market, which includes other NAAT technologies, is a large and diverse market. This market consists of three segments: the life science (research) NAAT market, the clinical NAAT market, and an "other" segment that includes forensics, environmental monitoring, veterinary, and other applications that do not involve life science research or human clinical (medical) applications. This report provides market size, growth, product information, trends and segmentation for the clinical PCR market. Sizing is provided for 2016 and forecasts to...Published: January 1, 2009 | Price: $3,995.00 – $7,990.00
Molecular diagnostics represents a revolution postponed, perhaps, but one that is now clearly underway. DNA Testing has emerged fully from research into clinical practice and becoming a dominant platform in clinical medicine. From Emerging to Emergent Technology Instrumentation now automates many of the sample preparation and assay steps that were formerly labor intensive. New tests are being launched all the time. At each step of the way, Kalorama Information has reported on its progress, and in this latest market research...Published: July 9, 2020 | Price: $5,500.00 – $11,000.00
Molecular Diagnostics could be said to be the most important part of in vitro diagnostics. This is especially true in the wake of COVID-19. Kalorama Information has, for many years, estimated the size of and forecasted the growth of the worldwide market for these important in vitro diagnostic tests in all major segments, and does so in this edition as a pandemic has reached developed markets including the United States. 2020 was set to be a year of growth and...Published: March 7, 2024 | Price: $5,000.00 – $10,500.00
Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has been covering mPOC on a regular basis since 2013. Our latest report, The Market and Future Potential for Molecular Point-of-Care (mPOC),...Published: June 6, 2019 | Price: $4,000.00 – $8,000.00
Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and...Published: February 12, 2020 | Price: $5,500.00 – $11,000.00
The potential of molecular diagnostic tools was initially recognized by onco-hematologists during the 1980s based on the observation that specific chromosomal translocations may significantly aid the diagnosis of various types of leukemia and lymphoma. Later, the emergence of user-friendly molecular methods such as PCR has opened up practical applications that helped multiple approaches for cancer diagnosis and treatments. DNA sequencing is increasingly employed in cancer molecular diagnostics. PCR is the initial step used in isolating and amplifying specific regions of...Published: April 7, 2022 | Price: $6,000.00 – $12,000.00
The Most Comprehensive and Reliable Market Sizing and Forecasts in Infectious Disease IVD [caption id="attachment_18836" align="aligncenter" width="300"] Attend a WEBINAR on this topic.[/caption] Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the...Published: May 26, 2017 | Price: $3,196.00 – $6,392.00
Lab Robotics Market analyzes the current and potential world revenues for diagnostic laboratory robotic systems. The report's revenue data provide multiple year forecasts for different product segments and revenue forecasts focus on segments where robotics plays an important role, including the following world market segments: The report's market data provide multiple year forecasts for different product segments and market forecasts focus on segments where robotics plays an important role, including the following world market segments: Specimen Transport Robots Systems, 2016-2021...Published: December 19, 2024 | Price: $3,950.00 – $7,875.00
The molecular diagnostics market, a driving force within the global in vitro diagnostics (IVD) industry, continues to thrive several years post-pandemic, offering significant growth opportunities across infectious diseases, cancer, and transplant diagnostics. Kalorama Information's latest report, The World Market for Molecular Diagnostics, 13th Edition, provides an unparalleled deep dive into this dynamic sector, revealing key trends, applications, and innovations shaping the market from 2024 to 2029. Why This Report is a Must-Have: Comprehensive Market Insights: Analyze global and regional molecular...Published: February 7, 2023 | Price: $5,000.00 – $10,000.00
This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market. The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market. Knowing these markets is essential to knowing the opportunity in point of care testing and microbiology IVD. Since 2013, Kalorama has been producing a dedicated...Published: April 12, 2017 | Price: $3,196.00 – $6,392.00
PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) Polymerase chain reaction (PCR) technology is used in life science (research) activities and also in clinical medicine. PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) includes opportunity estimates for both research and diagnostic uses of PCR, by geography, with forecasts to 2021; global analysis of PCR and other NAAT technologies; examination of the applications of PCR and other NAAT in research and...Published: November 19, 2024 | Price: $6,300.00 – $12,600.00
Stay Ahead of the Curve with Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029: With the global demand for infectious disease IVD products projected to surge, understanding market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern. Abstract As infectious diseases continue to pose significant global health challenges, diagnostic testing has emerged as a vital tool...Published: August 1, 2008 | Price: $2,995.00 – $5,000.00
A perfect supplemental information resource for customers who have already purchased The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition, The IVD Market Research Supplement bundle studies and quantifies in greater detail some of the important areas that will have a transforming impact on the diagnostic industry: • Companies are now performing diagnostic tests as a service rather than simply selling kit to laboratories. Are companies seeking profit, or a 'back-door' around FDA regulations? And does it have growth...Published: December 19, 2023 | Price: $3,750.00 – $7,500.00
Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market. The market was both boosted and challenged in unexpected ways by COVID-19. But where does the multi-billion-dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th Edition, reveals that post-pandemic the market remains ripe with opportunity, notably in the areas of infectious diseases, cancer, and transplant diagnostics. Global demand persists, with...Published: December 1, 2006 | Price: $4,500.00 – $9,990.00
The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices become established. This comprehensive report on the market for clinical in vitro diagnostic (IVD) tests in India covers both reagent and instrumentation markets for the...